Salas-Whalen, author of the book, Weightless: A Doctors Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve ," cited estimates that half of the world population will have obesity by 2030, which has implications on everything from rates of type 2 diabetes to certain cancers
Supported by Catalyst by Wellstar, a program led by Dr
[5] Examples [edit] Drugs belonging to this class are: Sitagliptin [6] (FDA approved in 2006, and marketed by Merck & Co
Wegovy via Novo partners)
(Ozempic is also approved to reduce cardiovascular and kidney-related risks in people with diabetes.) Is it safe to take a GLP-1 while breastfeeding
The article summarises a workshop held as part of the United in Hope: International PWS Conference 2025, where the Foundation for Prader-Willi Research (FPWR) and IPWSO brought clinicians together to compare experiences and discuss what information should be tracked in everyday care